GSK’s Blenrep Comeback On The Cards After Second Trial Win

 
• By Andrew McConaghie
  
GSK House, August 2022
GSK: the company once tipped Blenrep to earn $3bn in peak yearly sales.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip